Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Cost Analysis of Interstim Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00200031
Recruitment Status : Completed
First Posted : September 20, 2005
Last Update Posted : July 28, 2008
Sponsor:
Information provided by:
MedtronicNeuro

Brief Summary:
A study to examine the impact that Interstim Therapy for Urinary Control has on health care utilization and costs within a health care system and the satisfaction with treatment expressed by patients using this therapy.

Condition or disease Intervention/treatment
Urinary Retention and Symptoms of Overactive Bladder (Urge, Frequency) Device: Interstim therapy

Detailed Description:
A retrospective administrative data analysis combined with a prospective health related quality of life/satisfaction with treatment survey designed to examine the impact that Interstim Therapy for Urinary Control has had on health care utilization and costs for the Kaiser Permanente system and the satisfaction with treatment expressed by patients using this therapy.

Layout table for study information
Study Type : Observational
Enrollment : 150 participants
Official Title: Interstim Therapy Retrospective Cost Analysis and Quality of Life
Study Start Date : July 2005
Actual Study Completion Date : April 2006




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Criteria
Patients implanted with an Interstim Therapy for Urinary Control or undergoing test stimulation for potential placement of Interstim Therapy during the period of June 1, 2002 through June 30, 2004 and who are enrolled with Kaiser-Permanente of Southern California.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00200031


Locations
Layout table for location information
United States, California
Southern California Permanente Medical Group
Los Angeles, California, United States, 90027
Sponsors and Collaborators
MedtronicNeuro
Investigators
Layout table for investigator information
Principal Investigator: Sherif Aboseif, MD Kaiser Permanente
Publications of Results:
Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00200031    
Other Study ID Numbers: 4348
First Posted: September 20, 2005    Key Record Dates
Last Update Posted: July 28, 2008
Last Verified: July 2008
Additional relevant MeSH terms:
Layout table for MeSH terms
Urinary Bladder, Overactive
Urinary Retention
Urinary Bladder Diseases
Urologic Diseases
Lower Urinary Tract Symptoms
Urological Manifestations
Urination Disorders